All of the folloiwng statements about Ranolazine are true, except;
**Core Concept**
Ranolazine is an antianginal medication that works by inhibiting the late sodium current (late INa) in cardiac muscle cells. This action helps to reduce sodium-dependent calcium influx, leading to a decrease in intracellular calcium levels and a subsequent reduction in myocardial oxygen demand.
**Why the Correct Answer is Right**
Ranolazine is primarily used to treat chronic angina in patients who remain symptomatic despite optimal medical therapy. It has a unique mechanism of action that is distinct from other antianginal medications, such as beta-blockers and calcium channel blockers. By inhibiting the late sodium current, ranolazine reduces the frequency of angina attacks and improves exercise tolerance without causing significant changes in heart rate or blood pressure. This makes it an attractive option for patients who are intolerant to other antianginal medications.
**Why Each Wrong Option is Incorrect**
**Option A:** This statement is true and is actually a correct description of ranolazine's mechanism of action.
**Option B:** This statement is true and highlights the potential benefits of ranolazine in reducing angina frequency and improving exercise tolerance.
**Option C:** This statement is false and is incorrect. Ranolazine does not have a significant effect on heart rate or blood pressure, making it a useful option for patients who are intolerant to other antianginal medications.
**Clinical Pearl / High-Yield Fact**
Ranolazine is a good option for patients with chronic angina who remain symptomatic despite optimal medical therapy, particularly those who are intolerant to beta-blockers and calcium channel blockers. Its unique mechanism of action and lack of significant effects on heart rate or blood pressure make it a valuable addition to the treatment armamentarium.
**Correct Answer: C. Ranolazine does not have a significant effect on heart rate or blood pressure, making it a good option for patients who are intolerant to other antianginal medications.**